12.67

1.25% -0.16

Novocure Ltd (NVCR)

Overview News Price History Option Chain Financials Why NVCR Down? Discussions Forecast

Novocure Ltd stock is traded at $12.67, with a volume of 810.89K. It is down -1.25% in the last 24 hours and up +7.28% over the past month. NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Previous Close:

$12.83

Open:

$12.72

24h Volume:

810.89K

Relative Volume:

0.46

Market Cap:

$1.44B

Revenue:

$655.35M

Net Income/Loss:

$-136.23M

P/E Ratio:

-10.37

EPS:

-1.2223

Net Cash Flow:

$-75.68M

1W Performance:

+18.19%

1M Performance:

+7.28%

6M Performance:

-12.50%

1Y Performance:

-18.68%

1-Day Range:

$12.50

$13.07

1-Week Range:

$10.85

$13.17

52-Week Range:

$9.82

$20.06

Novocure Ltd Stock (NVCR) Company Profile

Name

Novocure Ltd

Sector

Healthcare (1114)

Industry

Medical Devices (142)

Phone

44 (0)15 3475 6700

Address

NO. 4 THE FORUM, ST. HELIER

Employee

1,605

Twitter

@novocure

Next Earnings Date

2026-04-30

Latest SEC Filings

NVCR's Discussions on Twitter

Compare NVCR vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NVCR Novocure Ltd	12.67	1.46B	655.35M	-136.23M	-75.68M	-1.2223
ABT Abbott Laboratories	96.00	168.22B	45.13B	6.28B	7.40B	3.5895
SYK Stryker Corp	338.34	131.49B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	85.00	110.66B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	60.99	95.46B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	81.44	46.69B	6.07B	1.06B	1.34B	1.8063

Novocure Ltd Stock (NVCR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-25-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Jul-08-25	Initiated	Ladenburg Thalmann	Buy
Dec-02-24	Upgrade	Evercore ISI	In-line → Outperform
Oct-16-24	Upgrade	H.C. Wainwright	Neutral → Buy
Nov-20-23	Resumed	JP Morgan	Neutral
Aug-28-23	Downgrade	H.C. Wainwright	Buy → Neutral
Aug-08-23	Upgrade	Piper Sandler	Neutral → Overweight
Aug-04-23	Initiated	SVB Securities	Outperform
Jul-31-23	Upgrade	Evercore ISI	Underperform → In-line
Jun-07-23	Upgrade	Wedbush	Underperform → Neutral
May-16-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Mar-17-23	Downgrade	JP Morgan	Neutral → Underweight
Jan-06-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Jan-05-23	Reiterated	H.C. Wainwright	Buy
Nov-29-22	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-24-22	Downgrade	Piper Sandler	Overweight → Neutral
Jul-05-22	Downgrade	Evercore ISI	In-line → Underperform
May-16-22	Initiated	H.C. Wainwright	Buy
Feb-08-22	Initiated	Loop Capital	Buy
Feb-02-22	Upgrade	Oppenheimer	Perform → Outperform
Jan-20-22	Upgrade	Truist	Hold → Buy
Jan-03-22	Upgrade	Evercore ISI	Underperform → In-line
Jul-01-21	Downgrade	Mizuho	Buy → Neutral
Apr-14-21	Downgrade	Wedbush	Neutral → Underperform
Jan-25-21	Reiterated	Piper Sandler	Overweight
Sep-23-20	Initiated	Northland Capital	Outperform
Sep-18-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Sep-17-20	Downgrade	Truist	Buy → Hold
Jun-01-20	Resumed	Oppenheimer	Perform
May-01-20	Downgrade	Oppenheimer	Outperform → Perform
Apr-09-20	Downgrade	Evercore ISI	In-line → Underperform
Mar-05-20	Upgrade	Wells Fargo	Equal Weight → Overweight
Jan-02-20	Downgrade	Evercore ISI	Outperform → In-line
Jul-29-19	Upgrade	SunTrust	Hold → Buy
Jul-26-19	Downgrade	JP Morgan	Overweight → Neutral
Jul-26-19	Downgrade	Wedbush	Outperform → Neutral
Mar-20-19	Initiated	SunTrust	Hold
Nov-02-18	Downgrade	Wells Fargo	Outperform → Market Perform
Jul-16-18	Initiated	Evercore ISI	Outperform
Apr-18-18	Reiterated	Mizuho	Buy
Feb-23-18	Reiterated	Mizuho	Buy
May-24-17	Upgrade	Wells Fargo	Market Perform → Outperform
Jul-29-16	Reiterated	Wedbush	Outperform
Jan-19-16	Initiated	Barclays	Underweight
Dec-02-15	Initiated	Deutsche Bank	Hold

View All

Novocure Ltd Stock (NVCR) Latest News

12:16 PM

Total debt per share of NovoCure Ltd. – SWB:038 - TradingView

12:16 PM

Apr 20, 2026

NovoCure Ltd stock (JE00B6T5S470): Is tumor treating fields therapy strong enough to unlock new upsi - AD HOC NEWS

Apr 20, 2026

[DEF 14A] NovoCure Ltd Definitive Proxy Statement - Stock Titan

Apr 20, 2026

Apr 18, 2026

NovoCure Ltd stock (JE00B6T5S470): Does tumor treating fields therapy hold the key to oncology break - AD HOC NEWS

Apr 18, 2026

Apr 16, 2026